ArticleFrontiers in oncology2022

Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology.

Filippo de Marinis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.